We are excited to announce that BEAMER will be attending the Amsterdam 2025 World Evidence, Pricing, and Access (EPA) Congress, Europe’s largest congress dedicated to market access, pricing, and evidence. From 5-6 March 2025, the event will feature over 300 speakers, 8 tracks, and 1500+ attendees from the pharma, biotech, and Payers/HTA sectors.

We are particularly proud to share that Claire Everitt, Design Engineering Team Lead and IMI Project Leader at Pfizer, from BEAMER, will be a speaker at this prestigious event.

The 2025 edition of the congress will take place over two days and will introduce the Health Economics & Outcomes Research (HEOR) track, along with a new poster area aimed at enhancing the academic presence at EPA. This addition promises to bring more content and depth to the discussions.

Key topics at the event will include Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence. Attendees will gain insights into the latest trends in reimbursement, payment models, affordability, HEOR, and other significant industry developments.

We are proud to be part of this world-leading forum that offers the opportunity to showcase our solutions and thought leadership to key stakeholders in the pharma and biotech industries.

We look forward to seeing you there!

We Would Be Happy to Hear Your Comments

Feel free to share your thoughts by contacting us: Contact Us

Contact us